The world’s leading manufacturer of DNA sequencing systems will pay $9.8 million to resolve allegations that it knowingly sold products with security vulnerabilities to federal agencies, Rhode ...

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

Genomics sequencing firm Illumina Inc. has agreed to pay $9.8 million to resolve False Claims Act whistleblower allegations ...

Illumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic ...

Illumina introduces next generation cancer research assay, TruSight Oncology 500: San Diego Friday, August 1, 2025, 12:00 Hrs [IST] Illumina Inc., a biotechnology company develops ...

Return on Equity (ROE): Waters's ROE stands out, surpassing industry averages. With an impressive ROE of 6.4%, the company demonstrates effective use of equity capital and strong financial performance ...

Revenue of $1.06 billion for Q2 2025, down 3% from Q2 2024 on both a reported and constant currency basis GAAP operating margin of 20.2% and non-GAAP operating margin ...